Mauro Gitto on Comparison of Paclitaxel-coated Balloons with Urea or Iopromide
Mauro Gitto, Interventional Cardiologist at Humanitas Research Hospital, shared on LinkedIn:
”Our latest article comparing two contemporary paclitaxel-coated balloons (urea-coated Prevail vs iopromide-coated Sequent Please) for the treatment of both de novo and ISR lesions.
As evidence in support of DCB-based PCI grows, more and more device-comparing studies are needed!
Full text here.”
Read the full article here.
Article: Paclitaxel-coated balloon with urea or iopromide as the excipient for treatment of coronary artery disease
Authors: Mauro Gitto, Francesco Tartaglia, Pier Pasquale Leone, Gianmaria Calamita, Alessandro Gabrielli, Leon Gramss, Marco Luciano Rossi, Damiano Regazzoli, Gabriele Gasparini, Ottavia Cozzi, Bernhard Reimers, Giulio Giuseppe Stefanini, Antonio Mangieri, Azeem Latib, Antonio Colombo
Stay updated on all scientific advances with Hemostasis Today.
-
Feb 3, 2026, 10:53Aurelio Maggio: The Final Chapter of Our Journey Through Thalassemia
-
Feb 3, 2026, 10:40Pedro Perez: Post-Thrombectomy DVT Recovery in 2026 – Closing the Loop on Outcomes
-
Feb 3, 2026, 10:26Ryan Williams: This Article Brings to Light The Complexity of PRP…
-
Feb 3, 2026, 10:05Tiago Lopes: Can AI Predict Immune Reactions of New Drugs? Yes!
-
Feb 3, 2026, 09:51Rucha Patil Reflects on 49th MHG Annual Conference and Essence of ASH 2025
-
Feb 3, 2026, 09:37Grigoris Gerotziafas on VTE in MM and BCMA: We Are Pleased to Announce Our New Systematic Review
-
Feb 3, 2026, 09:24Early-Bird Registration for the WFH 2026 World Congress is Now Open
-
Feb 3, 2026, 09:15Joshua Bernstock: Prehospital Stroke Triage Has Hit a Ceiling
-
Feb 3, 2026, 09:00A Major Highlight of 2025 and Honour For Me: Ashkan Shoamanesh at Huashan International Stroke Conference